Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 Oct 27

PMID 36289767

Authors

Nathalie di Clemente

Chrystele Racine

Rodolfo A Rey

Affiliations

Soon will be listed here.

Abstract

This article reviews the main findings on anti-Müllerian hormone (AMH) and its involvement in the pathogenesis of polycystic ovary syndrome (PCOS) and its male equivalent. In women, AMH is produced by granulosa cells from the mid-fetal life to menopause and is a reliable indirect marker of ovarian reserve. AMH protects follicles from atresia, inhibits their differentiation in the ovary, and stimulates gonadotrophin-releasing hormone neurons pulsatility. AMH overexpression in women with PCOS likely contributes to the increase of the follicle cohort and of androgen levels, leading to follicular arrest and anovulation. In the male, AMH is synthesized at high levels by Sertoli cells from fetal life to puberty when serum AMH falls to levels similar to those observed in women. AMH is involved in the differentiation of the genital tract during fetal life and plays a role in Sertoli and Leydig cells differentiation and function. Serum AMH is used to assess Sertoli cell function in children with disorders of sex development and various conditions affecting the hypothalamic-pituitary-testicular axis. Although the reproductive function of male relative of women with PCOS has been poorly investigated, adolescents have elevated levels of AMH which could play a detrimental role on their fertility.

Citing Articles

PepTune: Generation of Therapeutic Peptides with Multi-Objective-Guided Discrete Diffusion.

Tang S, Zhang Y, Chatterjee P ArXiv. 2025; .

PMID: 39764410 PMC: 11703324.

Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding.

Taieb A, Asma G, Jabeur M, Fatma B, Nassim B, Asma B Clin Med Insights Endocrinol Diabetes. 2024; 17:11795514241296777.

PMID: 39494232 PMC: 11528641. DOI: 10.1177/11795514241296777.

Stem cell-based therapeutic potential in female ovarian aging and infertility.

Cui X, Jing X J Ovarian Res. 2024; 17(1):171.

PMID: 39182123 PMC: 11344413. DOI: 10.1186/s13048-024-01492-3.

AMH in Males: Effects of Body Size and Composition on Serum AMH Levels.

Tandl V, Haudum C, Eberhard K, Hutz B, Foessl I, Kolesnik E J Clin Med. 2023; 12(13).

PMID: 37445513 PMC: 10342968. DOI: 10.3390/jcm12134478.

Molecular Research on Polycystic Ovary Syndrome (PCOS).

Daniele S, Chelucci E, Scarfo G, Artini P Biomedicines. 2023; 11(5).

PMID: 37239028 PMC: 10215849. DOI: 10.3390/biomedicines11051358.

References

Condorelli R, Cannarella R, Calogero A, La Vignera S . Evaluation of testicular function in prepubertal children. Endocrine. 2018; 62(2):274-280. DOI: 10.1007/s12020-018-1670-9. View

Barrett E, Hoeger K, Sathyanarayana S, Abbott D, Redmon J, Nguyen R . Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure. J Dev Orig Health Dis. 2018; 9(3):307-314. PMC: 5997496. DOI: 10.1017/S2040174417001118. View

Recabarren S, Smith R, Rios R, Maliqueo M, Echiburu B, Codner E . Metabolic profile in sons of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008; 93(5):1820-6. DOI: 10.1210/jc.2007-2256. View

Wissing M, Mikkelsen A, Kumar A, Kalra B, Pors S, Flachs E . Associations of different molecular forms of antimüllerian hormone and biomarkers of polycystic ovary syndrome and normal women. Fertil Steril. 2019; 112(1):149-155.e1. DOI: 10.1016/j.fertnstert.2019.03.002. View

Torchen L, Kumar A, Kalra B, Savjani G, Sisk R, Legro R . Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil Steril. 2016; 106(1):50-55. PMC: 4930891. DOI: 10.1016/j.fertnstert.2016.03.029. View

Gorsic L, Dapas M, Legro R, Hayes M, Urbanek M . Functional Genetic Variation in the Anti-Müllerian Hormone Pathway in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2019; 104(7):2855-2874. PMC: 6543512. DOI: 10.1210/jc.2018-02178. View

Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S . Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2006; 92(1):240-5. DOI: 10.1210/jc.2006-1582. View

Wang P, Koishi K, McGeachie A, Kimber M, MacLaughlin D, Donahoe P . Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc Natl Acad Sci U S A. 2005; 102(45):16421-5. PMC: 1283469. DOI: 10.1073/pnas.0508304102. View

Ohyama K, Ohta M, Hosaka Y, Tanabe Y, Ohyama T, Yamano Y . Expression of anti-Müllerian hormone and its type II receptor in germ cells of maturing rat testis. Endocr J. 2015; 62(11):997-1006. DOI: 10.1507/endocrj.EJ15-0370. View

10.

Moolhuijsen L, Visser J . Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab. 2020; 105(11). PMC: 7486884. DOI: 10.1210/clinem/dgaa513. View

11.

Barret J, Nicolas A, Jarry A, Dubreuil O, Meseure D, Passat T . The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer. Biology (Basel). 2021; 10(4). PMC: 8067808. DOI: 10.3390/biology10040305. View

12.

BEZARD J, Vigier B, Tran D, Mauleon P, Josso N . Immunocytochemical study of anti-Müllerian hormone in sheep ovarian follicles during fetal and post-natal development. J Reprod Fertil. 1987; 80(2):509-16. DOI: 10.1530/jrf.0.0800509. View

13.

Pellatt L, Rice S, Dilaver N, Heshri A, Galea R, Brincat M . Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril. 2011; 96(5):1246-51.e1. DOI: 10.1016/j.fertnstert.2011.08.015. View

14.

Mimouni N, Paiva I, Barbotin A, Timzoura F, Plassard D, Le Gras S . Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab. 2021; 33(3):513-530.e8. PMC: 7928942. DOI: 10.1016/j.cmet.2021.01.004. View

15.

Josso N, Picard J . Genetics of anti-Müllerian hormone and its signaling pathway. Best Pract Res Clin Endocrinol Metab. 2022; 36(1):101634. DOI: 10.1016/j.beem.2022.101634. View

16.

Fenichel P, Rey R, Poggioli S, Donzeau M, Chevallier D, Pointis G . Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. Hum Reprod. 1999; 14(8):2020-4. DOI: 10.1093/humrep/14.8.2020. View

17.

Teede H, Misso M, Costello M, Dokras A, Laven J, Moran L . Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2018; 89(3):251-268. PMC: 9052397. DOI: 10.1111/cen.13795. View

18.

Escobar-Morreale H . Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018; 14(5):270-284. DOI: 10.1038/nrendo.2018.24. View

19.

Bongrani A, Mellouk N, Rame C, Cornuau M, Guerif F, Froment P . Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction?. Int J Mol Sci. 2019; 20(15). PMC: 6695651. DOI: 10.3390/ijms20153778. View

20.

Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin S . Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun. 2016; 7:10055. PMC: 4729924. DOI: 10.1038/ncomms10055. View